Thermo Fisher Scientific Expects FY23 Revenue Of $43.4B-$44.0B, Vs. Consensus Of $45.21B, With Core Organic Revenue Growth Of 2%-4%, Forecasts Adjusted EPS Of $22.28-$22.72 Vs. Consensus Of $23.55
Portfolio Pulse from Benzinga Newsdesk
Thermo Fisher Scientific has projected its FY23 revenue to be between $43.4B and $44.0B, which is lower than the consensus estimate of $45.21B. The company also expects a core organic revenue growth of 2%-4% and forecasts an adjusted EPS of $22.28-$22.72, which is also below the consensus estimate of $23.55.
July 26, 2023 | 10:04 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Thermo Fisher Scientific's lower than expected FY23 revenue and EPS forecasts may negatively impact its stock price.
Thermo Fisher Scientific's FY23 revenue and EPS forecasts are lower than the consensus estimates. This could lead to a negative sentiment among investors, potentially causing a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100